Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.430
+0.270 (8.54%)
At close: Jan 17, 2025, 4:00 PM
3.460
+0.030 (0.87%)
After-hours: Jan 17, 2025, 7:58 PM EST
Perspective Therapeutics Employees
As of December 31, 2023, Perspective Therapeutics had 119 total employees, including 116 full-time and 3 part-time employees. The number of employees increased by 53 or 80.30% compared to the previous year.
Employees
119
Change
53
Growth
80.30%
Revenue / Employee
$13,084
Profits / Employee
-$536,008
Market Cap
231.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CATX News
- 14 days ago - Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - Bullish On Perspective Therapeutics: Early Successes And Large Oncology TAM - Seeking Alpha
- 4 weeks ago - Perspective Therapeutics: Definitely Not Looking Overvalued Now - Seeking Alpha
- 7 weeks ago - Perspective Therapeutics to Participate in Upcoming Investor Conferences in December - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024 - GlobeNewsWire
- 2 months ago - Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewsWire